MUCOMYST

Mucomyst Adverse Events Reported to the FDA Over Time

How are Mucomyst adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Mucomyst, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Mucomyst is flagged as the suspect drug causing the adverse event.

Most Common Mucomyst Adverse Events Reported to the FDA

What are the most common Mucomyst adverse events reported to the FDA?

Medication Error	19 (3.7%)
Hallucination	14 (2.73%)
Dyspnoea	12 (2.34%)
Asthenia	11 (2.14%)
Fatigue	11 (2.14%)
Pruritus	11 (2.14%)
Drug Exposure During Pregnancy	10 (1.95%)
Intra-uterine Death	9 (1.75%)
Condition Aggravated	8 (1.56%)
Dermatitis Exfoliative	8 (1.56%)
Pyrexia	8 (1.56%)
	Show More
Stillbirth	8 (1.56%)
Dizziness	7 (1.36%)
Drug Dispensing Error	7 (1.36%)
Metabolic Encephalopathy	7 (1.36%)
Rash	7 (1.36%)
Rash Erythematous	7 (1.36%)
Toxic Encephalopathy	7 (1.36%)
Urticaria	7 (1.36%)
Accidental Exposure	6 (1.17%)
Exposure To Toxic Agent	6 (1.17%)
Renal Failure	6 (1.17%)
Somnolence	6 (1.17%)
Throat Irritation	6 (1.17%)
Wrong Drug Administered	6 (1.17%)
Cough	5 (.97%)
Lethargy	5 (.97%)
Purpura	5 (.97%)
Rash Pustular	5 (.97%)
Abdominal Pain	4 (.78%)
Accidental Overdose	4 (.78%)
Bronchitis	4 (.78%)
Circumstance Or Information Capable...	4 (.78%)
Drug Ineffective	4 (.78%)
Encephalopathy	4 (.78%)
Eosinophilia	4 (.78%)
Hypoalbuminaemia	4 (.78%)
Hypokalaemia	4 (.78%)
Septic Shock	4 (.78%)
Acute Generalised Exanthematous Pus...	3 (.58%)
Agranulocytosis	3 (.58%)
Alpha Haemolytic Streptococcal Infe...	3 (.58%)
Asthma	3 (.58%)
Bacterial Infection	3 (.58%)
Blood Alkaline Phosphatase Increase...	3 (.58%)
Blood Culture Positive	3 (.58%)
Blood Pressure Decreased	3 (.58%)
Convulsion	3 (.58%)
Dialysis	3 (.58%)
Eczema	3 (.58%)
Incorrect Dose Administered	3 (.58%)
Livedo Reticularis	3 (.58%)
Nasopharyngitis	3 (.58%)
Oedema Peripheral	3 (.58%)
Pancreatitis Acute	3 (.58%)
Pharyngeal Oedema	3 (.58%)
Renal Graft Loss	3 (.58%)
Rhinorrhoea	3 (.58%)
Tachypnoea	3 (.58%)
Vomiting	3 (.58%)
Weight Decreased	3 (.58%)
White Blood Cell Count Increased	3 (.58%)
Abortion Spontaneous	2 (.39%)
Acute Respiratory Distress Syndrome	2 (.39%)
Anaphylactic Reaction	2 (.39%)
Anorexia	2 (.39%)
Bronchopleural Fistula	2 (.39%)
Burning Sensation	2 (.39%)
Cellulitis	2 (.39%)
Chest Pain	2 (.39%)
Death	2 (.39%)
Drug Dose Omission	2 (.39%)
Eating Disorder	2 (.39%)
Eosinophil Count Increased	2 (.39%)
Eye Disorder	2 (.39%)
Haematoma	2 (.39%)
Heart Rate Increased	2 (.39%)
Hepatitis	2 (.39%)
Incorrect Route Of Drug Administrat...	2 (.39%)
Intercostal Retraction	2 (.39%)
Laryngitis	2 (.39%)
Leukocytosis	2 (.39%)
Loss Of Consciousness	2 (.39%)
Malaise	2 (.39%)
Multi-organ Failure	2 (.39%)
Neutropenia	2 (.39%)
Normochromic Normocytic Anaemia	2 (.39%)
Oedema	2 (.39%)
Pneumonia	2 (.39%)
Pregnancy	2 (.39%)
Premature Baby	2 (.39%)
Rash Papular	2 (.39%)
Rash Pruritic	2 (.39%)
Renal Failure Acute	2 (.39%)
Respiratory Disorder	2 (.39%)
Respiratory Failure	2 (.39%)
Respiratory Fume Inhalation Disorde...	2 (.39%)
Rhabdomyolysis	2 (.39%)
Rhinitis	2 (.39%)
Skin Exfoliation	2 (.39%)
Tachycardia	2 (.39%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Mucomyst, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Mucomyst is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Mucomyst

What are the most common Mucomyst adverse events reported to the FDA?

Epidermal And Dermal Conditions	59 (11.5%)
Medication Errors	57 (11.11%)
Respiratory	40 (7.8%)
Infections - Pathogen Unspecified	30 (5.85%)
Neurological	22 (4.29%)
Abortions And Stillbirth	19 (3.7%)
Chemical Injury And Poisoning	19 (3.7%)
Encephalopathies	18 (3.51%)
Disturbances In Thinking	14 (2.73%)
White Blood Cell	13 (2.53%)
Bacterial Infectious	9 (1.75%)
	Show More
Cardiac And Vascular Investigations	9 (1.75%)
Gastrointestinal Signs	9 (1.75%)
Renal Disorders	9 (1.75%)
Body Temperature Conditions	8 (1.56%)
Skin Vascular Abnormalities	8 (1.56%)
Angiedema And Urticaria	7 (1.36%)
Hematology Investigations	7 (1.36%)
Bronchial Disorders	5 (.97%)
Therapeutic And Nontherapeutic Effe...	5 (.97%)
Anemias Nonhemolytic And Marrow Dep...	4 (.78%)
Electrolyte And Fluid Balance Condi...	4 (.78%)
Exocrine Pancreas Conditions	4 (.78%)
Hematological And Lymphoid Tissue T...	4 (.78%)
Hepatic And Hepatobiliary	4 (.78%)
Protein And Amino Acid Metabolism	4 (.78%)
Upper Respiratory Tract Disorders	4 (.78%)
Allergic Conditions	3 (.58%)
Cardiac Arrhythmias	3 (.58%)
Enzyme	3 (.58%)
Lower Respiratory Tract Disorders	3 (.58%)
Microbiology And Serology	3 (.58%)
Physical Examination Topics	3 (.58%)
Pregnancy, Labour, Delivery And Pos...	3 (.58%)
Procedural And Device Related Injur...	3 (.58%)
Seizures	3 (.58%)
Vascular Hemorrhagic	3 (.58%)
Appetite And General Nutritional	2 (.39%)
Eating Disorders	2 (.39%)
Eye	2 (.39%)
Fatal Outcomes	2 (.39%)
Heart Failures	2 (.39%)
Muscle	2 (.39%)
Neonatal And Perinatal Conditions	2 (.39%)
Oral Soft Tissue Conditions	2 (.39%)
Pleural	2 (.39%)
Product Quality Issues	2 (.39%)
Viral Infectious	2 (.39%)
Acid-base	1 (.19%)
Breast	1 (.19%)
Cardiac Therapeutic Procedures	1 (.19%)
Cervix Disorders	1 (.19%)
Congenital And Hereditary	1 (.19%)
Cornification And Dystrophic Skin	1 (.19%)
Hepatobiliary	1 (.19%)
Joint	1 (.19%)
Lifestyle Issues	1 (.19%)
Maternal Complications Of Pregnancy	1 (.19%)
Musculoskeletal And Connective Tiss...	1 (.19%)
Platelet	1 (.19%)
Protein And Chemistry Analyses	1 (.19%)
Psychiatric And Behavioural Symptom...	1 (.19%)
Skin Appendage Conditions	1 (.19%)
Spleen, Lymphatic And Reticulendoth...	1 (.19%)
Tongue Conditions	1 (.19%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Mucomyst, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Mucomyst is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.